Home > National Drug Code (NDC) > Lithium Carbonate

Lithium Carbonate - 63739-265-10 - (Lithium Carbonate)

Alphabetical Index


Drug Information of Lithium Carbonate

Product NDC: 63739-265
Proprietary Name: Lithium Carbonate
Non Proprietary Name: Lithium Carbonate
Active Ingredient(s): 300    mg/1 & nbsp;   Lithium Carbonate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Lithium Carbonate

Product NDC: 63739-265
Labeler Name: McKesson Packaging Services a business unit of McKesson Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076243
Marketing Category: ANDA
Start Marketing Date: 20070719

Package Information of Lithium Carbonate

Package NDC: 63739-265-10
Package Description: 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-265-10) > 10 CAPSULE in 1 BLISTER PACK

NDC Information of Lithium Carbonate

NDC Code 63739-265-10
Proprietary Name Lithium Carbonate
Package Description 10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-265-10) > 10 CAPSULE in 1 BLISTER PACK
Product NDC 63739-265
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lithium Carbonate
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20070719
Marketing Category Name ANDA
Labeler Name McKesson Packaging Services a business unit of McKesson Corporation
Substance Name LITHIUM CARBONATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Mood Stabilizer [EPC]

Complete Information of Lithium Carbonate


General Information